146 related articles for article (PubMed ID: 12534595)
21. Array-CGH analysis of cutaneous anaplastic large cell lymphoma.
Szuhai K; van Doorn R; Tensen CP; Van Kester
Methods Mol Biol; 2013; 973():197-212. PubMed ID: 23412792
[TBL] [Abstract][Full Text] [Related]
22. Clonal T cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in the skin and blood of patients with parapsoriasis and early-stage mycosis fungoides.
Klemke CD; Dippel E; Dembinski A; Pönitz N; Assaf C; Hummel M; Stein H; Goerdt S
J Pathol; 2002 Jul; 197(3):348-54. PubMed ID: 12115881
[TBL] [Abstract][Full Text] [Related]
23. Molecular cytogenetics in the study of cutaneous T-cell lymphomas (CTCL).
Karenko L; Hahtola S; Ranki A
Cytogenet Genome Res; 2007; 118(2-4):353-61. PubMed ID: 18000390
[TBL] [Abstract][Full Text] [Related]
24. Reversible resistance to apoptosis in cutaneous T cell lymphoma.
Meech SJ; Edelson R; Walsh P; Norris DA; Duke RC
Ann N Y Acad Sci; 2001 Sep; 941():46-58. PubMed ID: 11594582
[TBL] [Abstract][Full Text] [Related]
25. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.
Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
J Am Acad Dermatol; 2001 Feb; 44(2):253-60. PubMed ID: 11174383
[TBL] [Abstract][Full Text] [Related]
26. Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma.
Aviles A; Neri N; Fernandez-Diez J; Silva L; Nambo MJ
Hematology; 2015 Oct; 20(9):538-42. PubMed ID: 25592781
[TBL] [Abstract][Full Text] [Related]
27. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
Wu K; Lund M; Bang K; Thestrup-Pedersen K
Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous T-cell lymphoma: molecular and cytogenetic findings.
Sterry W
Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):13-7. PubMed ID: 17474354
[TBL] [Abstract][Full Text] [Related]
29. Array-based CGH of primary cutaneous CD8+ aggressive EPIDERMO-tropic cytotoxic T-cell lymphoma.
Fanoni D; Corti L; Alberti-Violetti S; Tensen CP; Venegoni L; Vermeer M; Willemze R; Berti E
Genes Chromosomes Cancer; 2018 Dec; 57(12):622-629. PubMed ID: 30307677
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
31. Spectral karyotyping demonstrates genetically unstable skin-homing T lymphocytes in cutaneous T-cell lymphoma.
Padilla-Nash HM; Wu K; Just H; Ried T; Thestrup-Pedersen K
Exp Dermatol; 2007 Feb; 16(2):98-103. PubMed ID: 17222222
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic abnormalities in patients with cutaneous T-cell lymphomas.
Whang-Peng J; Bunn P; Knutsen T; Schechter GP; Gazdar AF; Matthews MJ; Minna JD
Cancer Treat Rep; 1979 Apr; 63(4):575-80. PubMed ID: 312695
[TBL] [Abstract][Full Text] [Related]
33. Chromosomal aberration patterns differ in subtypes of primary cutaneous B cell lymphomas.
Hallermann C; Kaune KM; Siebert R; Vermeer MH; Tensen CP; Willemze R; Gunawan B; Bertsch HP; Neumann C
J Invest Dermatol; 2004 Jun; 122(6):1495-502. PubMed ID: 15175042
[TBL] [Abstract][Full Text] [Related]
34. Banding studies of chromosomes in a patient with mycosis fungoides.
Fukuhara S; Rowley JD; Variakojis D
Cancer; 1978 Nov; 42(5):2262-8. PubMed ID: 719606
[TBL] [Abstract][Full Text] [Related]
35. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
Nevala H; Karenko L; Vakeva L; Ranki A
Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
37. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
[TBL] [Abstract][Full Text] [Related]
38. Chromosome studies in mycosis fungoides.
van Vloten WA; Pet EA; Geraedts JP
Br J Dermatol; 1980 May; 102(5):507-13. PubMed ID: 7387897
[TBL] [Abstract][Full Text] [Related]
39. CD13 and TCR clone: markers of early mycosis fungoides.
Bernier C; Nguyen JM; Quéreux G; Renault JJ; Bureau B; Dreno B
Acta Derm Venereol; 2007; 87(2):155-9. PubMed ID: 17340024
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinase-2 promoter genotype as a marker of cutaneous T-cell lymphoma early stage.
Vasku A; Vasku JB; Necas M; Vasku V
J Biomed Biotechnol; 2010; 2010():805907. PubMed ID: 20625418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
